Correction to: British Journal of Cancer (2008) 98, 571–579. doi:10.1038/sj.bjc.6604181
The authors wish to add an acknowledgement to their paper, recently published online (AOP) and in this issue.
The final sentence of the Acknowledgements section should now read (additional acknowledgement in bold).
‘This work was supported by Breast Cancer Campaign (FD and EK), Breast Cancer Research Trust (MS, G-XK and EK), Medical Research Council (DF and EK), Research Promotion Fund from the University of Essex (FD, IC and EK) and by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases (ZKA, SP and VL); VD was supported by a PhD studentship from the BBSRC, UK; NP is Clinical Fellow supported by the Essex Rivers NHS Trust’.
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1038/sj.bjc.6604181
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
D'Arcy, V., Pore, N., Docquier, F. et al. Erratum: BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours. Br J Cancer 98, 676 (2008). https://doi.org/10.1038/sj.bjc.6604255
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6604255
